'Medicare CBD Pilot Will Allow Some THC in Products'- Cannabis Wire

The Medicare CBD pilot program will now permit the inclusion of some THC in CBD products, marking a significant regulatory change. This development may impact companies in the cannabis sector, including Canopy Growth Corporation (CGC), as they adapt to new market opportunities. The pilot aims to explore the effects of THC in CBD formulations on patient health outcomes.